NR4A1 and breast cancer: With regard to the status of hormone receptors, BC survivors were at a significantly high risk for developing TC when both the estrogen receptor (ER) and progesterone receptor (PR) were positive (SIR 1.26, 95% CI [1.15, 1.37]).